Grantable
RARE BIRD FOUNDATION
rare-bird.org
Working with our partners worldwide , Rare Bird aims to create the first-ever globally approved drug to tackle the transcription factor Myocyte Enhancer Factor 2C MEF2C deficiency within five years.
Ask me anything about this funder — whether they're a fit for your mission and how to approach them.
One free message · powered by Grantable AI
Welcome to Grantable
Sign in to start building your grant-ready profile
or
We'll send you a one-time verification code. No password needed. By signing in you agree to our Terms of Service and Privacy Policy.